Literature DB >> 3301662

Arterial and venous compliance in sustained essential hypertension.

M E Safar, G M London.   

Abstract

Arterial and venous compliances are decreased in men with sustained essential hypertension. The reduced arterial compliance acts to maintain systolic pressure and end-systolic stress, thus contributing to the development of cardiac hypertrophy. Since cardiac output remains within the normal range in the hypertrophied hypertensive heart, elevated left ventricular pressures, and therefore increased cardiac filling pressures, are necessary if an adequate stroke volume is to be maintained. In hypertensive persons, reduced venous compliance acts to maintain the filling pressure of the heart in the presence of reduced intravascular volume. In patients with hypertension, even if compliance changes have been initiated by the elevated blood pressure itself, the reduced arterial and venous compliance observed in cross-sectional studies is not simply the mechanical consequence of the elevated blood pressure, but also reflects intrinsic alterations of the vascular wall. Consequently, blood pressure reduction caused by antihypertensive agents is not constantly associated with a reversion of the decreased vascular compliance. Such observations may be of importance in the consideration of cardiovascular morbidity and mortality in patients treated for hypertension.

Entities:  

Mesh:

Year:  1987        PMID: 3301662     DOI: 10.1161/01.hyp.10.2.133

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

1.  Influence of arterial compliance on presence and extent of ischaemia during stress echocardiography.

Authors:  B A Haluska; K Matthys; R Fathi; E Rozis; S G Carlier; T H Marwick
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

2.  Requirement for functional BK channels in maintaining oscillation in venomotor tone revealed by species differences in expression of the β1 accessory subunits.

Authors:  Hui Xu; Sachin S Kandlikar; Erika B Westcott; Gregory D Fink; James J Galligan
Journal:  J Cardiovasc Pharmacol       Date:  2012-01       Impact factor: 3.105

Review 3.  Arterial compliance and blood pressure.

Authors:  S J Marchais; A P Guerin; B Pannier; G Delavaud; G M London
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Attenuation of contractile responses to sympathetic co-transmitters in veins from subjects with essential hypertension.

Authors:  H Lind; D Erilnge; J Brunkwall; L Edvinsson
Journal:  Clin Auton Res       Date:  1997-04       Impact factor: 4.435

Review 5.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

6.  The effects of anti-hypertensive therapy on the structural, mechanical and metabolic properties of the rat aorta.

Authors:  J F Clark; G K Radda; E A Boehm
Journal:  J Muscle Res Cell Motil       Date:  2000-04       Impact factor: 2.698

Review 7.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

8.  Growth in utero, adult blood pressure, and arterial compliance.

Authors:  C N Martyn; D J Barker; S Jespersen; S Greenwald; C Osmond; C Berry
Journal:  Br Heart J       Date:  1995-02

9.  Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues.

Authors:  Theodora Szasz; Susan Eddy; Joseph Paulauskis; Robert Burnett; Merete Ellekilde; Juan L Iovanna; Stephanie W Watts
Journal:  J Vasc Res       Date:  2009-06-30       Impact factor: 1.934

10.  Oxidative stress contributes to the augmented exercise pressor reflex in peripheral arterial disease patients.

Authors:  Matthew D Muller; Rachel C Drew; Cheryl A Blaha; Jessica L Mast; Jian Cui; Amy B Reed; Lawrence I Sinoway
Journal:  J Physiol       Date:  2012-09-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.